microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.
Glioblastoma (GBM) is the most frequently diagnosed malignant human glioma, and current median patient survival is less than two years despite maximal surgery followed by temozolomide chemoradiation therapies. Novel microRNA-related therapies are now being developed for cancers such as GBM. Differen...
Main Authors: | Bahauddeen M Alrfaei, Raghu Vemuganti, John S Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3828259?pdf=render |
Similar Items
-
MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells
by: Bahauddeen M. Alrfaei PhD, et al.
Published: (2020-09-01) -
Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis
by: Megan J. Ritter, et al.
Published: (2021-11-01) -
Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
by: Marcel Dreer, et al.
Published: (2016-04-01) -
GEI-8, a homologue of vertebrate nuclear receptor corepressor NCoR/SMRT, regulates gonad development and neuronal functions in Caenorhabditis elegans.
by: Pavol Mikoláš, et al.
Published: (2013-01-01) -
Smrt
by: Jean-Claude Poizat, et al.
Published: (2020-02-01)